US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mural Oncology

2.45

-0.0200-0.81%

Volume:171.43K

Turnover:421.14K

Market Cap:42.31M

PE:-0.32

High:2.49

Open:2.45

Low:2.44

Close:2.47

Loading ...

Overview Company News Filings

Mural Oncology Plc Elects Directors at Annual Meeting

Mural Oncology plc Conducted Annual General Meeting

FORM 8.1(a) & (b) - Mural Oncology plc

Unusually active option classes on open April 21st

This Week's Unlock Schedule: Tokens such as UDS, VENOM, and MURA will experience a one-time large unlock this week

Crude Oil Moves Lower; Citigroup Posts Upbeat Results

Mural Oncology Shares Jump as it Seeks Strategic Alternatives; Co. Discontinues Nemvaleukin Alfa Development

MT Newswires Live

BRIEF-Mural Oncology Announces Plans To Explore Strategic Alternatives

Mural Oncology to Explore Strategic Alternatives, Cut Workforce by 90%; Shares Jump Pre-Bell

MT Newswires Live

Mural Oncology to Explore Options, Cut 90% of Workforce

Mural Oncology Announces Plans to Explore Strategic Alternatives

THOMSON REUTERS

Mural Oncology Plc - to Explore Strategic Alternatives, Reduce Workforce by 90%

THOMSON REUTERS

Mural Oncology Plc - Not in Active Discussions With Any Potential Offeror

THOMSON REUTERS

Mural Oncology Announces Plans to Explore Strategic Alternatives

Mural Oncology Is Maintained at Buy by HC Wainwright & Co.

EUROPE RESEARCH ROUNDUP-ArcelorMittal, Ferrari Group, Sodexo

Top Midday Decliners

MT Newswires Live

Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley

Raymond James downgrades Mural Oncology Plc (MURA) to a Buy

Raymond James Downgrades Mural Oncology to Outperform From Strong Buy, $6 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MURA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.45,"timestamp":1750449600000,"preClose":2.47,"halted":0,"volume":171430,"delay":0,"floatShares":11282267,"shares":17268881,"eps":-7.668418,"marketStatus":"Pre-Mkt","change":-0.02,"latestTime":"06-23 04:21:55 EDT","open":2.45,"high":2.49,"low":2.44,"amount":421140.046614,"amplitude":0.020243,"askPrice":3.14,"askSize":100,"bidPrice":2.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.668418,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750685400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.45,"postHourTrading":{"tag":"盘后","latestPrice":2.45,"preClose":2.45,"latestTime":"17:53 EDT","volume":122,"amount":300.705,"timestamp":1750456420677},"volumeRatio":1.329926211348346,"impliedVol":0.4267,"impliedVolPercentile":0.2289},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MURA\",,,,,undefined,":{"symbol":"MURA","floatShares":11282267,"roa":"-43.80%","roe":"-76.27%","lyrEps":-7.5799,"volumeRatio":1.329926211348346,"shares":17268881,"dividePrice":0,"high":2.49,"amplitude":0.020243,"preClose":2.47,"low":2.44,"week52Low":0.95,"pbRate":"0.39","week52High":4.74,"institutionHeld":0,"latestPrice":2.45,"eps":-7.668418,"divideRate":0,"volume":171430,"delay":0,"ttmEps":-7.668418,"open":2.45,"prevYearClose":3.22,"prevWeekClose":2.45,"prevMonthClose":2.62,"prevQuarterClose":1.26,"fiveDayClose":2.53,"twentyDayClose":2.76,"sixtyDayClose":1.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MURA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543409475","title":"Mural Oncology Plc Elects Directors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543409475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543409475?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:17","pubTimestamp":1749763034,"startTime":"0","endTime":"0","summary":"An update from Mural Oncology Plc ( ($MURA) ) is now available. On June 11, 2025, Mural Oncology Plc held its annual general meeting where sharehol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mural-oncology-plc-elects-directors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mural-oncology-plc-elects-directors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2543424235","title":"Mural Oncology plc Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543424235","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543424235?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:18","pubTimestamp":1749759526,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL2wTx5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2532967140","title":"FORM 8.1(a) & (b) - Mural Oncology plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2532967140","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532967140?lang=en_us&edition=fundamental","pubTime":"2025-05-01 03:07","pubTimestamp":1746040020,"startTime":"0","endTime":"0","summary":"OPENING POSITION DISCLOSURE UNDER RULE 8.1 AND  OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE. Owner or controller of interests and short positions disclosed, if different from 1:The naming of nominee or vehicle companies is insufficient. For a trust, the trustee, settlor and beneficiaries must be named.Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree. Is the discloser the offeror or the offeree?Date position held:The latest practicable date prior to the disclosure. In addition to the company in 1 above, is the discloser also making disclosures in respect of any other party to the offer?If it is a cash offer or possible cash offer, state “N/A”。If there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1, copy table 2 for each additional class of relevant security.Interests and short positions in t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/form-8-1-b-mural-190700341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FORM","IE00B19Z6F94.USD","MURA","BK4147","BK4139","BK4602"],"gpt_icon":0},{"id":"2529807567","title":"Unusually active option classes on open April 21st","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529807567?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:40","pubTimestamp":1745242820,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Mural Oncology PLC (MURA), General Electric (GE), Barrick Gold (GOLD), TeraWulf (WULF), AMC En...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-april-21st-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-april-21st-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0075056555.USD","LU1223083913.SGD","MURA","LU1093756325.SGD","SG9999001143.SGD","LU1261432733.SGD","LU1280957306.USD","LU2756315664.SGD","LU0498741890.SGD","BK4017","LU0943347566.SGD","BK4547","LU0345780281.USD","LU0345770308.USD","LU0640476718.USD","LU0496367417.USD","BK4108","LU0055631609.USD","LU0820561909.HKD","BK4532","AMC","LU0630314457.HKD","LU0345781412.USD","BK4588","LU0368265764.SGD","BK4566","GOLD","LU0354030438.USD","LU0820561818.USD","LU1023059493.AUD","LU0157215616.USD","LU0354030511.USD","LU1064131342.USD","LU0820562030.AUD","LU1988902786.USD","BK4501","BK4600","WULF","LU0330918003.SGD","LU2543165471.USD","LU0724618789.USD","LU1366192091.USD","LU0689472784.USD","LU0788108826.HKD","LU0345780521.USD","BK4570","LU1366333091.USD","LU1551013342.USD","GE","LU1551013425.SGD"],"gpt_icon":0},{"id":"2529815234","title":"This Week's Unlock Schedule: Tokens such as UDS, VENOM, and MURA will experience a one-time large unlock this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2529815234","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529815234?lang=en_us&edition=fundamental","pubTime":"2025-04-21 09:05","pubTimestamp":1745197500,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 21st, according to Token Unlocks data, this week UDS, VENOM, and MURA will undergo a large one-time token unlock, including:Undeads Games  will unlock 21.94 million tokens worth approximately $14.89 million, accounting for 30.54% of the circulating supply, on April 27th at 8:00;Venom  will unlock 59.26 million tokens worth approximately $8.18 million, accounting for 2.86% of the circulating supply, on April 25th at 16:00;Murasaki  will unlock 10 million tokens worth approximately $4.01 million, accounting for 1% of the circulating supply, on April 23rd at 8:00;IOTA  will unlock 15.16 million tokens worth approximately $2.54 million, accounting for 0.41% of the circulating supply, on April 30th at 8:00.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/290481","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2527447547","title":"Crude Oil Moves Lower; Citigroup Posts Upbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2527447547","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527447547?lang=en_us&edition=fundamental","pubTime":"2025-04-16 00:10","pubTimestamp":1744733440,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44819308/dow-gains-100-points-citigroup-posts-upbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU2456880835.USD","LU2125154935.USD","BK4116","LU0098860793.USD","APLD","LU0170899867.USD","NVIW.SI","LU0162691827.USD","LU2462157665.USD","LU1201861249.SGD","SKYE","BK4583","SPRB","BK4585","C","BK4534","LU0072461881.USD","LU0130102774.USD","LU0320765646.SGD","QLD","MNQmain","USAW.SI","LU0052756011.USD","USJW.SI","LU1267930227.SGD","RZLV","LU0128525689.USD","BK4566","LU0648001328.SGD","BK4609","MURA","LU2417539215.USD","GOVX","NQmain","BK4023",".IXIC","IE00BSNM7G36.USD","QID","BK4504","TQQQ","TSYW.SI","LU1791807156.HKD","LU2360032135.SGD","LU1668664300.SGD","BK4608","PSQ","BK4588","SQQQ"],"gpt_icon":1},{"id":"2527442582","title":"Mural Oncology Shares Jump as it Seeks Strategic Alternatives; Co. Discontinues Nemvaleukin Alfa Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2527442582","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527442582?lang=en_us&edition=fundamental","pubTime":"2025-04-15 23:52","pubTimestamp":1744732325,"startTime":"0","endTime":"0","summary":"Mural Oncology's  shares jumped more than 160% in recent trading Tuesday after the company said it is discontinuing all clinical development of nemvaleukin alfa and plans to immediately start exploring strategic alternatives.The move follows the review of data from its phase 2 ARTISTRY-6 trial in melanoma, which failed to achieve the primary endpoint, and previously announced adverse results from the phase 3 ARTISTRY-7 trial in platinum-resistant ovarian cancer, the Ireland-based clinical-stage immuno-oncology company said.The company has engaged Lucid Capital Markets LLC as financial adviser for the exploration of strategic alternatives, which would include an offer for or other acquisition of the company, merger, or business combination. The company also said it will reduce its workforce by roughly 90%.As of Dec. 31, 2024, the company had approximately $144.4 million of cash and cash equivalents, and marketable securities.Price: 3.02, Change: +1.99, Percent Change: +193.30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2527341447","title":"BRIEF-Mural Oncology Announces Plans To Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2527341447","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527341447?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:24","pubTimestamp":1744723453,"startTime":"0","endTime":"0","summary":"BRIEF-Mural Oncology Announces Plans To Explore Strategic AlternativesApril 15 (Reuters) - Mural Oncology PLC MURA.O:MURAL ONCOLOGY ANNOUNCES PLANS TO EXPLORE STRATEGIC ALTERNATIVESMURAL ONCOLOGY PLC ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAFYXMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2527419757","title":"Mural Oncology to Explore Strategic Alternatives, Cut Workforce by 90%; Shares Jump Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2527419757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527419757?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:59","pubTimestamp":1744721953,"startTime":"0","endTime":"0","summary":"Mural Oncology  said Tuesday it plans to explore strategic alternatives following a review of data from its phase 2 trial in melanoma and previously announced results from the phase 3 trial in platinum-resistant ovarian cancer.The company said it is discontinuing all clinical development of nemvaleukin alfa and cutting its workforce by about 90%.Mural said it has hired Lucid Capital Markets to serve as its financial adviser in connection with the exploration of strategic alternatives, adding that there was no assurance that the process will lead to any transaction.The company said it has not received any approaches and was not in active discussions with any potential suitor.Mural Oncology climbed by more than 95% in premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2527416092","title":"Mural Oncology to Explore Options, Cut 90% of Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2527416092","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527416092?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:54","pubTimestamp":1744721640,"startTime":"0","endTime":"0","summary":"Mural Oncology shares more than doubled in premarket trading Tuesday after the clinical-stage immuno-oncology company said it will explore strategic alternatives and shed the bulk of its staff after throwing in the towel on its lead product candidate.Mural on Tuesday said it is ending all clinical development of its proposed nemvaleukin alfa cancer treatment and focusing on maximizing shareholder value.The Dublin-based company said it plans to cut 104 jobs, or roughly 90% of its workforce, resulting on costs of $9 million to $10 million.Mural said the move follows a review of data from its Phase 2 study of nemvaleukin alfa in melanoma, as well as previously announced results from a Phase 3 study in platinum-resistant ovarian cancer.Mural said it plans to explore potential options, including a sale of the company, adding that it hasn't received any approaches nor is it in active talks with any potential buyer.Mural sports a market capitalization of about $17.75 million based on Monday's","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2527901294","title":"Mural Oncology Announces Plans to Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2527901294","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527901294?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAFYXMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2527490157","title":"Mural Oncology Plc - to Explore Strategic Alternatives, Reduce Workforce by 90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527490157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527490157?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAFYXMS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2527490155","title":"Mural Oncology Plc - Not in Active Discussions With Any Potential Offeror","url":"https://stock-news.laohu8.com/highlight/detail?id=2527490155","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527490155?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUAFYXMS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2527181904","title":"Mural Oncology Announces Plans to Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2527181904","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527181904?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718400,"startTime":"0","endTime":"0","summary":"Following review of data from the phase 2 ARTISTRY-6 trial and previously announced results from the phase 3 ARTISTRY-7 trial, Mural will discontinue all clinical development of nemvaleukin With $144.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/15/3061678/0/en/Mural-Oncology-Announces-Plans-to-Explore-Strategic-Alternatives.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4596","MURA","BK4099","BK4555","LCID","BK4139"],"gpt_icon":1},{"id":"2522820171","title":"Mural Oncology Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522820171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522820171?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:59","pubTimestamp":1742986740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 06:59 ET (10:59 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MURA"],"gpt_icon":0},{"id":"2522381217","title":"EUROPE RESEARCH ROUNDUP-ArcelorMittal, Ferrari Group, Sodexo","url":"https://stock-news.laohu8.com/highlight/detail?id=2522381217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522381217?lang=en_us&edition=fundamental","pubTime":"2025-03-26 16:14","pubTimestamp":1742976862,"startTime":"0","endTime":"0","summary":"EUROPE RESEARCH ROUNDUP-ArcelorMittal, Ferrari Group, SodexoMarch 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ArcelorMittal, Fer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3N3Q90LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU2089284900.SGD","LU0128525689.USD","BK5021","LU0072461881.USD","LU1019632923.USD","LU1894683348.USD","KGF.UK","LU0949170426.SGD","LU0251132253.USD","LU1363072403.SGD","LU0965509283.SGD","LU1037948897.HKD","LU0175139822.USD","LU0048584097.USD","LU1934455194.USD","LU2125154935.USD","LU0203347892.USD","LU2023250504.SGD","LU2265009873.SGD","IE00BSNM7G36.USD","LU1035777561.USD","LU1019634622.SGD","RJF","LU0225283273.USD","LU0889566641.SGD","LU1242518857.USD","LU0109981661.USD","LU0788109394.HKD","MURA","SHEL.UK","LU1883839398.USD","BK4139","LU0792757196.USD","LU0965509010.AUD","LU2106854487.HKD","GB00BDT5M118.USD","ADT1.UK","LU0289941410.SGD","LU1267930813.SGD","LU0985489474.SGD","FUTR.UK","LU0321505868.SGD","LU0171293334.USD","IE00B64PRP62.GBP","BK4127","LU0345781412.USD","LU0310800379.SGD","LU2125154778.USD","FSFL.UK"],"gpt_icon":0},{"id":"2522188162","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2522188162","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522188162?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:57","pubTimestamp":1742929058,"startTime":"0","endTime":"0","summary":"Mural Oncology  said Tuesday it will stop the development of nemvaleukin alfa for platinum-resistant ovarian cancer as it believes a phase 3 trial of the drug combined with Merck's  Keytruda is \"highly unlikely to achieve success\" at the final analysis.Shares of Mural slumped 59% following an increase in intraday trading volume to over 3.52 million from a daily average of about 156,000.Cassava Sciences  said that topline results from its phase 3 REFOCUS-ALZ study of simufilam showed no treatment benefit for patients with mild-to-moderate Alzheimer's disease.The biotech company said the results did not meet the co-primary, secondary, and exploratory biomarker endpoints.Shares sank 33%, with intraday trading volume rising to over 13.8 million versus a daily average of about 1.96 million.Price: 1.53, Change: -2.30, Percent Change: -60.05","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1585245621.USD","SG9999001176.USD","MURA","LU1116320901.HKD","LU1941712264.USD","SG9999015341.SGD","LU1929549753.HKD","LU0265550359.USD","IE00BLSP4452.SGD","LU0006306889.USD","BK4588","LU1983299246.USD","LU2324357040.USD","LU1066051498.USD","BK4534","SAVA","LU1069347547.HKD","BK4007","LU1934455194.USD","LU1989772923.USD","IE00BLSP4239.USD","LU0265550946.USD","LU0208291251.USD","LU0266013472.USD","SG9999014575.USD","LU1066053197.SGD","BK4533","LU1023059063.AUD","SG9999013999.USD","LU0106261372.USD","SG9999001176.SGD","LU1291159041.SGD","BK4516","LU0238689110.USD","LU1035773651.USD","LU1934455863.HKD","LU1093756168.USD","LU2023250504.SGD","LU2361045086.USD","LU0965508806.USD","BK4585","LU1093756325.SGD","LU1162221912.USD","LU0965509101.SGD","LU0058720904.USD","MRK","LU0289739699.SGD","LU1699723380.USD","BK4550","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2522886668","title":"Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2522886668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522886668?lang=en_us&edition=fundamental","pubTime":"2025-03-26 01:59","pubTimestamp":1742925581,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded Mural Oncology (MURA) to Equal Weight from Overweight and removed the firm’s prior $13 price target after removing the pl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mural-oncology-downgraded-to-equal-weight-from-overweight-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mural-oncology-downgraded-to-equal-weight-from-overweight-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MURA"],"gpt_icon":0},{"id":"2522853878","title":"Raymond James downgrades Mural Oncology Plc (MURA) to a Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853878?lang=en_us&edition=fundamental","pubTime":"2025-03-26 00:15","pubTimestamp":1742919327,"startTime":"0","endTime":"0","summary":"In a report released today, Laura Prendergast from Raymond James downgraded Mural Oncology Plc (MURA – Research Report) to a Buy, with a price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/raymond-james-downgrades-mural-oncology-plc-mura-to-a-buy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/raymond-james-downgrades-mural-oncology-plc-mura-to-a-buy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MURA","RJF"],"gpt_icon":0},{"id":"2522002595","title":"Raymond James Downgrades Mural Oncology to Outperform From Strong Buy, $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2522002595","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522002595?lang=en_us&edition=fundamental","pubTime":"2025-03-26 00:07","pubTimestamp":1742918864,"startTime":"0","endTime":"0","summary":"Mural Oncology (MURA) has an average rating of buy and mean price target of $16, according to analysts polled by FactSet.Price: 1.50, Change: -2.33, Percent Change: -60.84","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RJF","MURA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MURA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MURA","date":"2025-06-20","current":-0.326267,"percent":0.691643,"low":-0.567064,"twenty":-0.413191,"median":-0.350402,"eighty":-0.308355,"high":-0.133414,"avg":-0.357392,"sd":0.072154,"marketCap":42654136},"quantilePoints":[{"date":"2024-01-05","current":-0.481599,"twenty":-0.478881,"median":-0.474804,"eighty":-0.470727,"marketCap":94630786},{"date":"2024-01-12","current":-0.410251,"twenty":-0.486355,"median":-0.471406,"eighty":-0.445585,"marketCap":80611410},{"date":"2024-01-19","current":-0.3423,"twenty":-0.481599,"median":-0.439979,"eighty":-0.393263,"marketCap":67259623},{"date":"2024-01-26","current":-0.394962,"twenty":-0.471406,"median":-0.400483,"eighty":-0.374577,"marketCap":77607258},{"date":"2024-02-02","current":-0.377974,"twenty":-0.468009,"median":-0.394962,"eighty":-0.374577,"marketCap":74269311},{"date":"2024-02-09","current":-0.361836,"twenty":-0.439979,"median":-0.387742,"eighty":-0.372878,"marketCap":71098262},{"date":"2024-02-16","current":-0.422992,"twenty":-0.422992,"median":-0.393263,"eighty":-0.372878,"marketCap":83114870},{"date":"2024-02-23","current":-0.394962,"twenty":-0.419594,"median":-0.394962,"eighty":-0.374237,"marketCap":77607258},{"date":"2024-03-01","current":-0.449322,"twenty":-0.440489,"median":-0.397934,"eighty":-0.375256,"marketCap":88288687},{"date":"2024-03-08","current":-0.463762,"twenty":-0.455438,"median":-0.398359,"eighty":-0.376785,"marketCap":91125942},{"date":"2024-03-15","current":-0.409401,"twenty":-0.455438,"median":-0.402181,"eighty":-0.377804,"marketCap":80444513},{"date":"2024-03-22","current":-0.371179,"twenty":-0.454589,"median":-0.401757,"eighty":-0.376785,"marketCap":72934133},{"date":"2024-03-28","current":-0.403798,"twenty":-0.451361,"median":-0.400058,"eighty":-0.375086,"marketCap":83766622},{"date":"2024-04-05","current":-0.375246,"twenty":-0.449322,"median":-0.398359,"eighty":-0.374978,"marketCap":77843730},{"date":"2024-04-12","current":-0.350774,"twenty":-0.445245,"median":-0.39751,"eighty":-0.372198,"marketCap":72766965},{"date":"2024-04-19","current":-0.291224,"twenty":-0.441508,"median":-0.394962,"eighty":-0.366932,"marketCap":60413503},{"date":"2024-04-26","current":-0.287961,"twenty":-0.440319,"median":-0.393263,"eighty":-0.354313,"marketCap":59736601},{"date":"2024-05-03","current":-0.311618,"twenty":-0.439979,"median":-0.38392,"eighty":-0.342979,"marketCap":64644141},{"date":"2024-05-10","current":-0.309986,"twenty":-0.43845,"median":-0.382221,"eighty":-0.327769,"marketCap":64305690},{"date":"2024-05-17","current":-0.343069,"twenty":-0.428768,"median":-0.378823,"eighty":-0.318307,"marketCap":65833885},{"date":"2024-05-24","current":-0.316611,"twenty":-0.420444,"median":-0.375426,"eighty":-0.318307,"marketCap":60756722},{"date":"2024-05-31","current":-0.295445,"twenty":-0.417386,"median":-0.374577,"eighty":-0.316082,"marketCap":56694991},{"date":"2024-06-07","current":-0.294563,"twenty":-0.413309,"median":-0.372878,"eighty":-0.310639,"marketCap":56525752},{"date":"2024-06-14","current":-0.291035,"twenty":-0.410081,"median":-0.371179,"eighty":-0.308355,"marketCap":55848797},{"date":"2024-06-21","current":-0.286626,"twenty":-0.409401,"median":-0.368234,"eighty":-0.301829,"marketCap":55002603},{"date":"2024-06-28","current":-0.270751,"twenty":-0.409061,"median":-0.366932,"eighty":-0.301173,"marketCap":51956305},{"date":"2024-07-05","current":-0.264578,"twenty":-0.407601,"median":-0.361535,"eighty":-0.298647,"marketCap":50771634},{"date":"2024-07-12","current":-0.28839,"twenty":-0.40373,"median":-0.353221,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-07-15","current":-0.28839,"twenty":-0.403661,"median":-0.351997,"eighty":-0.295445,"marketCap":55341081},{"date":"2024-08-02","current":-0.30691,"twenty":-0.403593,"median":-0.350774,"eighty":-0.295445,"marketCap":58895095},{"date":"2024-08-09","current":-0.28839,"twenty":-0.402946,"median":-0.34384,"eighty":-0.294206,"marketCap":55341081},{"date":"2024-08-16","current":-0.309698,"twenty":-0.402097,"median":-0.3423,"eighty":-0.293345,"marketCap":53669674},{"date":"2024-08-23","current":-0.322479,"twenty":-0.400738,"median":-0.337815,"eighty":-0.294206,"marketCap":55884613},{"date":"2024-08-30","current":-0.320512,"twenty":-0.399365,"median":-0.334277,"eighty":-0.294563,"marketCap":55543853},{"date":"2024-09-06","current":-0.314613,"twenty":-0.398685,"median":-0.332486,"eighty":-0.294916,"marketCap":54521574},{"date":"2024-09-13","current":-0.309698,"twenty":-0.398359,"median":-0.332045,"eighty":-0.295445,"marketCap":53669674},{"date":"2024-09-20","current":-0.340176,"twenty":-0.398359,"median":-0.331604,"eighty":-0.295445,"marketCap":58951452},{"date":"2024-09-27","current":-0.2979,"twenty":-0.398019,"median":-0.327395,"eighty":-0.295798,"marketCap":51625115},{"date":"2024-10-04","current":-0.314613,"twenty":-0.396762,"median":-0.323462,"eighty":-0.296327,"marketCap":54521574},{"date":"2024-10-11","current":-0.336243,"twenty":-0.395369,"median":-0.327395,"eighty":-0.296327,"marketCap":58269932},{"date":"2024-10-18","current":-0.362789,"twenty":-0.394962,"median":-0.331327,"eighty":-0.296956,"marketCap":62870190},{"date":"2024-10-25","current":-0.343125,"twenty":-0.394282,"median":-0.332398,"eighty":-0.2979,"marketCap":59462592},{"date":"2024-10-31","current":-0.350008,"twenty":-0.393263,"median":-0.332486,"eighty":-0.298033,"marketCap":60655251},{"date":"2024-11-08","current":-0.33231,"twenty":-0.391781,"median":-0.332486,"eighty":-0.298629,"marketCap":57588412},{"date":"2024-11-15","current":-0.387645,"twenty":-0.387286,"median":-0.33396,"eighty":-0.298901,"marketCap":59610428},{"date":"2024-11-22","current":-0.374316,"twenty":-0.385465,"median":-0.33526,"eighty":-0.298973,"marketCap":57560786},{"date":"2024-11-29","current":-0.443181,"twenty":-0.393263,"median":-0.336243,"eighty":-0.298973,"marketCap":68150604},{"date":"2024-12-06","current":-0.455399,"twenty":-0.39564,"median":-0.339193,"eighty":-0.299866,"marketCap":70029443},{"date":"2024-12-13","current":-0.415413,"twenty":-0.398359,"median":-0.339541,"eighty":-0.300736,"marketCap":63880516},{"date":"2024-12-20","current":-0.348769,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":53632305},{"date":"2024-12-27","current":-0.353212,"twenty":-0.398359,"median":-0.340176,"eighty":-0.301829,"marketCap":54315519},{"date":"2025-01-03","current":-0.355433,"twenty":-0.398359,"median":-0.34173,"eighty":-0.302962,"marketCap":54657126},{"date":"2025-01-10","current":-0.405416,"twenty":-0.398359,"median":-0.343097,"eighty":-0.304593,"marketCap":62343284},{"date":"2025-01-17","current":-0.409859,"twenty":-0.401077,"median":-0.344248,"eighty":-0.306233,"marketCap":63026498},{"date":"2025-01-24","current":-0.435406,"twenty":-0.40373,"median":-0.345715,"eighty":-0.306728,"marketCap":66954979},{"date":"2025-01-31","current":-0.418745,"twenty":-0.408369,"median":-0.346075,"eighty":-0.30678,"marketCap":64392927},{"date":"2025-02-07","current":-0.492053,"twenty":-0.409859,"median":-0.34988,"eighty":-0.307074,"marketCap":75665959},{"date":"2025-02-14","current":-0.473171,"twenty":-0.413191,"median":-0.351865,"eighty":-0.307731,"marketCap":72762299},{"date":"2025-02-21","current":-0.468728,"twenty":-0.415413,"median":-0.353212,"eighty":-0.307731,"marketCap":72079085},{"date":"2025-02-28","current":-0.406527,"twenty":-0.418745,"median":-0.354323,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-07","current":-0.39653,"twenty":-0.416524,"median":-0.35567,"eighty":-0.308355,"marketCap":60976856},{"date":"2025-03-14","current":-0.486438,"twenty":-0.418745,"median":-0.357655,"eighty":-0.308355,"marketCap":62514088},{"date":"2025-03-21","current":-0.518803,"twenty":-0.425409,"median":-0.358364,"eighty":-0.309698,"marketCap":66673486},{"date":"2025-03-28","current":-0.180978,"twenty":-0.428742,"median":-0.357873,"eighty":-0.308355,"marketCap":23258192},{"date":"2025-04-04","current":-0.164891,"twenty":-0.425409,"median":-0.357272,"eighty":-0.30691,"marketCap":21190797},{"date":"2025-04-11","current":-0.133414,"twenty":-0.422992,"median":-0.355433,"eighty":-0.303717,"marketCap":17145595},{"date":"2025-04-17","current":-0.32442,"twenty":-0.42226,"median":-0.354323,"eighty":-0.301829,"marketCap":41692464},{"date":"2025-04-25","current":-0.353912,"twenty":-0.421188,"median":-0.355237,"eighty":-0.303339,"marketCap":45482688},{"date":"2025-05-02","current":-0.349891,"twenty":-0.419189,"median":-0.353912,"eighty":-0.305469,"marketCap":44965839},{"date":"2025-05-09","current":-0.347209,"twenty":-0.418745,"median":-0.353217,"eighty":-0.30656,"marketCap":44621273},{"date":"2025-05-16","current":-0.333407,"twenty":-0.416968,"median":-0.353212,"eighty":-0.306743,"marketCap":43587576},{"date":"2025-05-23","current":-0.363252,"twenty":-0.415635,"median":-0.353567,"eighty":-0.306878,"marketCap":47489422},{"date":"2025-05-30","current":-0.348722,"twenty":-0.415413,"median":-0.353217,"eighty":-0.307403,"marketCap":45589845},{"date":"2025-06-06","current":-0.339476,"twenty":-0.415373,"median":-0.352957,"eighty":-0.307731,"marketCap":44381024},{"date":"2025-06-13","current":-0.334192,"twenty":-0.414053,"median":-0.351901,"eighty":-0.308105,"marketCap":43690268},{"date":"2025-06-20","current":-0.326267,"twenty":-0.413191,"median":-0.350402,"eighty":-0.308355,"marketCap":42654136}],"updateTime":1750666847887}}}